You have 9 free searches left this month | for more free features.

City

Middlesex (1)

Nagoya (1)

Condition

Fibrodyplasia Ossificans Progressiva (FOP) (1)

Fibrodysplasia Ossificans Progressiva (1)

Heterotopic Ossification (HO) (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 3 (2)

Sponsor

Regeneron Pharmaceuticals (2)

Collaborator

Intervention

garetosmab (2)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

garetosmab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Fibrodysplasia Ossificans Progressiva Trial (Garetosmab, Placebo)

Recruiting

Fibrodysplasia Ossificans Progressiva

Garetosmab
Placebo

Nagoya, Aichi, Japan
+1 more

Jan 17, 2023

Fibrodyplasia Ossificans Progressiva (FOP), Heterotopic Ossification (HO) Trial (garetosmab)

Withdrawn

Fibrodyplasia Ossificans Progressiva (FOP)
Heterotopic Ossification (HO)

garetosmab

(no location specified)

Oct 25, 2021